$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| DATO-DXD IMPROVED PFS IN BREAST CANCER | 25 Sep 2023 |
| ALEXION COMPLETES PFIZER GENE THERAPY AGREEMENT | 20 Sep 2023 |
| ENHERTU RECOMMENDED IN EU FOR HER2-MUTANT NSCLC | 15 Sep 2023 |
| FASENRA PHASE III EGPA TRIAL MET PRIMARY ENDPOINT | 11 Sep 2023 |
| UPDATE ON US REVIEW OF ULTOMIRIS FOR NMOSD | 06 Sep 2023 |
| TOTAL VOTING RIGHTS | 01 Sep 2023 |
| 25-NSE | 16 Aug 2023 |
| TOTAL VOTING RIGHTS | 01 Aug 2023 |
| ALEXION ENTERS GENE THERAPY AGREEMENT WITH PFIZER | 28 Jul 2023 |
| FORM 6K | 28 Jul 2023 |
| BEYFORTUS APPROVED IN US FOR INFANT RSV PREVENTION | 17 Jul 2023 |
| TOTAL VOTING RIGHTS | 03 Jul 2023 |
| DATO-DXD SIGNIFICANTLY IMPROVED PFS IN LUNG CANCER | 03 Jul 2023 |
| ANNUAL REPORT | 28 Jun 2023 |
| ASTRAZENECA AGREEMENT WITH QUELL THERAPEUTICS | 09 Jun 2023 |
| NIRSEVIMAB RECOMMENDED FOR INFANT RSV PROTECTION | 09 Jun 2023 |
| IMFINZI IMPROVED PCR IN GASTRIC AND GEJ CANCERS | 02 Jun 2023 |
| BLOCK LISTING INTERIM REVIEW | 01 Jun 2023 |
| TOTAL VOTING RIGHTS | 01 Jun 2023 |
| LYNPARZA APPROVED IN US FOR BRCAM PROSTATE CANCER | 01 Jun 2023 |
